English
Specials
My Feed
Moneycontrol PRO
you are here:

Regeneron Pharmaceuticals

SYMBOL:REGN|SECTOR:Health Care|DERIVED:CFD
i
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices are indicative only and not appropriate for trading purposes. Therefore Moneycontrol doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
$
2
2
1
1
.
3
3
7
7
5
5
5.90 (1.04%)

As on 06 Sep, 2025 | 01:29 IST

Day Range
565.15
577.75
LH
52 Week Range
476.79
1,170.58
LH
Advance Chart
Open565.00
Previous Close567.22
Beta-0.10
High577.75
Low565.15
TTM EPS See historical trend   45.64(+2.42% YoY)
52 Week High1,170.58
52 Week Low476.79
TTM PE See historical trend    12.56(Low PE)
Mkt. Cap ($ Billion)62.92
Dividend Yield0.34

Advanced Chart

*Delayed by 20 seconds

MC Technicals

Technical rating
i
This represents current trend.
Click here  for disclaimer.
Trend
Neutral
See Details  
Historical Rating  
Moving AveragesNeutral
Technical IndicatorsNeutral
Moving Averages CrossoversNeutral

Pivot levels

TypeR1R2R3PPS1S2S3
Classic579.43 591.80 601.71569.52 557.15 547.24 534.87
Fibonacci578.03 583.29 591.80569.52 561.01 555.75 547.24
Camarilla569.09 571.13 573.18569.52 565.01 562.97 560.92

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Moving Averages
Days
5572.56
10577.82
20574.32
50559.11
100558.04
200632.61

Returns

Price Performance
1 Week
-2.74%
1 Month2.66%
3 Months
-5.30%
YTD
-19.53%
1 Year
-51.40%
3 Years
-3.30%

Financialsin million $

Peers

NamePrice ($)Change%M.Cap(Billion $)TTM PETTM EPSDY52 wk high/lowTechnical Rating
Eli Lilly732.30-0.25695.17123.705.920.96746.56/0.00-13.33Neutral
J&J175.46-0.75422.3816.7310.492.88177.67/0.0012.33Neutral
AbbVie207.90-0.08366.9517.4411.924.39210.41/0.007.73Bearish
Merck83.22-1.01211.1726.933.092.5385.48/0.000.24Bearish
Amgen313.690.42163.2417.4917.423.52329.72/215.32-1.81Bearish
+ See More

Market news

Wall Street indexes end lower as jobs data fuels economic worries

September 6, 2025 10:13 AM
Show More

About the company

Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The Company commercializes medicines and product candidates for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, Kevzara (sarilumab) Solution for Subcutaneous Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion.